Hill-Rom Holdings Inc (NYSE:HRC) issued an update on its FY18 earnings guidance on Friday morning. The company provided EPS guidance of $4.22-4.30 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.29. The company issued revenue guidance of +3-4% y/y (approx $2.825-2.852), compared to the consensus revenue estimate of $2.87 billion.Hill-Rom Holdings also updated its Q1 guidance to $0.77-0.79 EPS.
Hill-Rom Holdings Inc (NYSE:HRC) traded down $3.39 on Friday, hitting $77.50. 1,219,951 shares of the stock traded hands, compared to its average volume of 446,033. The company has a current ratio of 1.76, a quick ratio of 1.33 and a debt-to-equity ratio of 1.67. The firm has a market cap of $5.27 billion, a P/E ratio of 21.50, a price-to-earnings-growth ratio of 1.65 and a beta of 1.19.
Hill-Rom Holdings (NYSE:HRC) last posted its earnings results on Friday, November 3rd. The medical technology company reported $1.32 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.27 by $0.05. Hill-Rom Holdings had a net margin of 4.27% and a return on equity of 19.99%. The business had revenue of $738.30 million for the quarter, compared to analyst estimates of $731.10 million. During the same quarter in the prior year, the firm earned $1.18 EPS. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. analysts predict that Hill-Rom Holdings Inc will post 3.82 EPS for the current fiscal year.
A number of equities research analysts have commented on the stock. Zacks Investment Research lowered shares of Hill-Rom Holdings from a hold rating to a sell rating in a report on Wednesday, August 2nd. BidaskClub lowered shares of Hill-Rom Holdings from a strong-buy rating to a buy rating in a report on Monday, July 24th. Needham & Company LLC cut their target price on shares of Hill-Rom Holdings from $95.00 to $93.00 and set a buy rating on the stock in a research report on Friday, July 28th. Cantor Fitzgerald set a $86.00 target price on shares of Hill-Rom Holdings and gave the company a hold rating in a research report on Friday, July 28th. Finally, Stifel Nicolaus reiterated a buy rating and issued a $84.00 price target on shares of Hill-Rom Holdings in a research report on Sunday, July 30th. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The stock presently has an average rating of Buy and a consensus target price of $87.29.
In other Hill-Rom Holdings news, SVP Andreas G. Frank sold 6,870 shares of the business’s stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $77.48, for a total transaction of $532,287.60. Following the completion of the transaction, the senior vice president now owns 16,701 shares of the company’s stock, valued at $1,293,993.48. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Andreas G. Frank sold 3,940 shares of the business’s stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $77.84, for a total value of $306,689.60. Following the transaction, the senior vice president now directly owns 16,701 shares of the company’s stock, valued at approximately $1,300,005.84. The disclosure for this sale can be found here. 2.20% of the stock is owned by insiders.
ILLEGAL ACTIVITY WARNING: This article was first published by Community Financial News and is owned by of Community Financial News. If you are reading this article on another website, it was illegally stolen and reposted in violation of international trademark & copyright laws. The legal version of this article can be accessed at https://www.com-unik.info/2017/11/04/hill-rom-holdings-inc-hrc-issues-fy18-earnings-guidance.html.
About Hill-Rom Holdings
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
What are top analysts saying about Hill-Rom Holdings Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Hill-Rom Holdings Inc and related companies.